相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。What Drives Amyloid Molecules To Assemble into Oligomers and Fibrils?
Jeremy D. Schmit et al.
BIOPHYSICAL JOURNAL (2011)
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Satish Kumar Singh
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Prediction of Immunogenicity of Therapeutic Proteins Validity of Computational Tools
Christine J. Bryson et al.
BIODRUGS (2010)
5th European Antibody Congress 2009
Alain Beck et al.
mAbs (2010)
The immunogenicity of humanized and fully human antibodies Residual immunogenicity resides in the CDR regions
Fiona A. Harding et al.
MABS (2010)
Exploring the sequence determinants of amyloid structure using position-specific scoring matrices
Sebastian Maurer-Stroh et al.
NATURE METHODS (2010)
The Immune Epitope Database 2.0
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2010)
Potential Aggregation-Prone Regions in Complementarity-Determining Regions of Antibodies and Their Contribution Towards Antigen Recognition: A Computational Analysis
Xiaoling Wang et al.
PHARMACEUTICAL RESEARCH (2010)
Immunological mechanism underlying the immune response to recombinant human protein therapeutics
Melody Sauerborn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Aggregation-Prone Motifs in Human Immunoglobulin G
Naresh Chennamsetty et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Immunogenicity of Aggregates of Recombinant Human Growth Hormone in Mouse Models
Amber Haynes Fradkin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality
John F. Carpenter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Potential aggregation prone regions in biotherapeutics A survey of commercial monoclonal antibodies
Xiaoling Wang et al.
MABS (2009)
Design of therapeutic proteins with enhanced stability
Naresh Chennamsetty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins
Sebastian Pechmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dynamics of factor VIII interactions determine its immunologic fate in hemophiliaA
Sebastien Lacroix-Desmazes et al.
BLOOD (2008)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
Anne S. De Groot et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Safety-related regulatory actions for biologicals approved in the United States and the European Union
Thijs J. Giezen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Bacterial inclusion bodies contain amyloid-like structure
Lei Wang et al.
PLOS BIOLOGY (2008)
Atomic structures of amyloid cross-β spines reveal varied steric zippers
Michael R. Sawaya et al.
NATURE (2007)
A role for protein misfolding in immunogenicity of biopharmaceuticals
Coen Maas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools
Jason A. Greenbaum et al.
JOURNAL OF MOLECULAR RECOGNITION (2007)
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
Leonard G. Presta
ADVANCED DRUG DELIVERY REVIEWS (2006)
Structure-function engineering of interferon-β-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation
Amartya Basu et al.
BIOCONJUGATE CHEMISTRY (2006)
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Recent atomic models of amyloid fibril structure
R Nelson et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Clinical link between MHC class II haplotype and interferon-beta (IFN-beta) immunogenicity
MDFS Barbosa et al.
CLINICAL IMMUNOLOGY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
3D structure of Alzheimer's amyloid-β(1-42) fibrils
T Lührs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences
GG Tartaglia et al.
PROTEIN SCIENCE (2005)
Structure of the cross-β spine of amyloid-like fibrils
R Nelson et al.
NATURE (2005)
Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules
CX Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification and removal of a promiscuous CD4+T cell epitope from the C1 domain of factor VIII
TD Jones et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
AM Fernandez-Escamilla et al.
NATURE BIOTECHNOLOGY (2004)
β Edge strands in protein structure prediction and aggregation
JA Siepen et al.
PROTEIN SCIENCE (2003)
Preclinical safety evaluation of monoclonal antibodies
R Foulkes
TOXICOLOGY (2002)
Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions
AJ Godkin et al.
JOURNAL OF IMMUNOLOGY (2001)
Antibody humanization: a case of the 'Emperor's new clothes'?
M Clark
IMMUNOLOGY TODAY (2000)
分享论文
